Harm Prevention

Prevent Heart Failure Readmissions and Improve Quality

Heart failure admissions occur with 22 percent of all patients discharged—the highest rate of any readmissions event.
Many characteristics of heart failure events complicate treatment and increase readmissions risks. Most people entering the hospital with heart failure get admitted immediately, often with no intervening assessment or treatment. Many patients don’t comply with drug or dietary care guidance after their discharge, representing two-thirds of heart failure readmissions. And the readmissions for heart failure happen fast, with an average time of 12 days.

Heart failure is prevalent and pervasive:
  • 5.7 million American adults live with heart failure (Ziaeian & Gregg, 2016)
  • One million hospitalizations for heart failure occur annually (Gheorghiade, Vaduganathan, Fonarow, & Bonow, 2013)
  • 70% of heart failure readmissions are for non-heart failure diagnoses, most commonly other cardiovascular conditions, pulmonary disease, and infections (Davis, et al., 2017)
  • There are 500,000 new cases of heart failure each year in the United States (Ogah, 2017)

Heart failure will increase 46% from 2012 to 2030, with greater than 8 million adults living with the chronic condition.

(Ziaeian & Gregg, 2016)

Reimbursement Penalties in Full Force

Hospitals addressing readmissions performance must act quickly. CMS uses three full years of data to determine penalties, so hospitals need to document and report positive performance data as quickly as possible to cycle it into the three-year rolling sample.

The full 3 percent penalties for reimbursement are now in place. The reduced payments apply to all Medicare admissions—not just those that resulted in readmissions.

Patient and Healthcare Impact

Heart failure readmissions cost $7,580 per episode (Davis, et al., 2017)—costing a mid-sized to large hospital with 1,000 discharges and 220 readmissions about $1.7 million.
The Jvion Heart Failure Vector has reduced readmissions for the condition by as much as 60 percent. That would eliminate 132 of the 220 annual readmissions—a savings of $1,000,000.
Extrapolated across the 1,000,000 heart failure admissions annually, the Jvion Machine has a potential to improve outcomes for 130,000 patients and save more than $1 trillion in healthcare costs.

Davis, J. D., Olsen, M. A., Bommarito, K., LaRue, S., Saeed, M., Rich , M. W., & Vader, J. M. (2017). All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter. The American Journal of Medicine, 130(1), 93.e9-93.e28. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482409/

Fitch, K., Engel, T., & Lau, J. (2017). The Cost of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis. Milliman, 1-29. Retrieved from http://us.milliman.com/uploadedFiles/insight/2017/cost-bruden-worsening-heart-failure.pdf

Gheorghiade, M., Vaduganathan, M., Fonarow, G. C., & Bonow, R. O. (2013). Rehospitalization for Heart Failure. Journal of American College of Cardiology, 61(4), 391-403. Retrieved from https://www.sciencedirect.com/science/article/pii/S0735109712052965?via%3Dihub

Ogah, O. A. (2017). Heart Failure: Definition classification, and pathophysiology - a mini-review. Nigerian Journal of Cardiology, 14(1), 9. Retrieved from http://www.nigjcardiol.org/citation.asp?issn=0189-7969;year=2017;volume=14;issue=1;spage=9;epage=14;aulast=Adebayo;aid=NigJCardiol_2017_14_1_9_201913

Ziaeian, B., & Gregg, F. C. (2016). The Prevention of Hospital Readmissions in Heart Failure. Progress in Cardiovascular Disease, 58(4), 379-385. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783289/

Jvion's Thinking Machine

We created a machine that thinks like a clinician. Here is how we did it.

Immerse Yourself in the Jvion Machine

Take just 2.5 minutes to dive into the world of prescriptive analytics for preventable harm.

The Jvion Machine in Action

See firsthand how the Jvion machine can help your patients and your organization.